• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于肽免疫原构建的基于硫氧还蛋白的高性能支架:用人乳头瘤病毒表位进行概念验证测试。

A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope.

作者信息

Canali Elena, Bolchi Angelo, Spagnoli Gloria, Seitz Hanna, Rubio Ivonne, Pertinhez Thelma A, Müller Martin, Ottonello Simone

机构信息

1] Department of Life Sciences, Biochemistry and Molecular Biology Unit, University of Parma, Italy [2].

Department of Life Sciences, Biochemistry and Molecular Biology Unit, University of Parma, Italy.

出版信息

Sci Rep. 2014 Apr 22;4:4729. doi: 10.1038/srep04729.

DOI:10.1038/srep04729
PMID:24751665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3994442/
Abstract

Escherichia coli thioredoxin has been previously exploited as a scaffold for the presentation/stabilization of peptide aptamers as well as to confer immunogenicity to peptide epitopes. Here we focused on other key features of thioredoxin that are of general interest for the production of safer and more effective peptide immunogens, such as a high thermal stability, lack of cross-reactivity and a low-cost of production. We identified thioredoxin from the archaebacterium Pyrococcus furiosus (PfTrx) as a novel scaffold meeting all the above criteria. PfTrx is a highly thermostable and protease-resistant scaffold with a strong (poly)peptide solubilisation capacity. Anti-PfTrx antibodies did not cross-react with mouse, nor human thioredoxin. Untagged PfTrx bearing a previously identified HPV16-L2 peptide epitope was obtained in a >90% pure form with a one-step thermal purification procedure and effectively elicited the production of neutralizing anti-HPV antibodies. We thus propose PfTrx as a superior, general-purpose scaffold for the construction of safe, stable, and low-cost peptide immunogens.

摘要

大肠杆菌硫氧还蛋白此前已被用作展示/稳定肽适配体以及赋予肽表位免疫原性的支架。在此,我们关注硫氧还蛋白的其他关键特性,这些特性对于生产更安全、更有效的肽免疫原具有普遍意义,例如高热稳定性、无交叉反应性以及低成本生产。我们从嗜热栖热菌(Pyrococcus furiosus,PfTrx)中鉴定出硫氧还蛋白作为满足上述所有标准的新型支架。PfTrx是一种高度耐热且抗蛋白酶的支架,具有很强的(多)肽溶解能力。抗PfTrx抗体与小鼠或人硫氧还蛋白均无交叉反应。携带先前鉴定出的HPV16 - L2肽表位的无标签PfTrx通过一步热纯化程序以>90%的纯度获得,并有效引发了中和性抗HPV抗体的产生。因此,我们提议将PfTrx作为构建安全、稳定且低成本肽免疫原的优质通用支架。

相似文献

1
A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope.一种用于肽免疫原构建的基于硫氧还蛋白的高性能支架:用人乳头瘤病毒表位进行概念验证测试。
Sci Rep. 2014 Apr 22;4:4729. doi: 10.1038/srep04729.
2
Secretory production of designed multipeptides displayed on a thermostable bacterial thioredoxin scaffold in Pichia pastoris.在毕赤酵母中,展示在热稳定细菌硫氧还蛋白支架上的设计多肽的分泌生产。
Protein Expr Purif. 2017 Jan;129:150-157. doi: 10.1016/j.pep.2016.04.012. Epub 2016 Apr 29.
3
Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.次要衣壳蛋白L2多表位诱导针对致癌性和黏膜型人乳头瘤病毒的广泛保护。
J Virol. 2018 Jan 30;92(4). doi: 10.1128/JVI.01930-17. Print 2018 Feb 15.
4
Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles.基于热稳定硫氧还蛋白-L2 多表位纳米颗粒的单分子 HPV 疫苗诱导的广谱中和抗病毒反应。
Sci Rep. 2017 Dec 21;7(1):18000. doi: 10.1038/s41598-017-18177-1.
5
Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin.由展示在细菌硫氧还蛋白上的HPV16 L2(20 - 38)肽串联重复序列诱导产生的强效抗人乳头瘤病毒免疫反应。
Vaccine. 2009 Mar 18;27(13):1949-56. doi: 10.1016/j.vaccine.2009.01.102. Epub 2009 Jan 31.
6
Lipidated L2 epitope repeats fused with a single-chain antibody fragment targeting human FcγRI elicited cross-neutralizing antibodies against a broad spectrum of human papillomavirus types.与靶向人FcγRI的单链抗体片段融合的脂化L2表位重复序列引发了针对多种人乳头瘤病毒类型的交叉中和抗体。
Vaccine. 2016 Nov 4;34(46):5531-5539. doi: 10.1016/j.vaccine.2016.10.009. Epub 2016 Oct 8.
7
Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.用代表HPV16次要衣壳蛋白L2表面区域片段的合成肽免疫兔子诱导产生的抗血清对HPV16、18、31和58假病毒颗粒进行中和。
Virology. 2007 Feb 20;358(2):266-72. doi: 10.1016/j.virol.2006.08.037. Epub 2006 Sep 28.
8
Thioredoxin-Displayed Multipeptide Immunogens.硫氧还蛋白展示的多聚肽免疫原。
Methods Mol Biol. 2015;1348:137-51. doi: 10.1007/978-1-4939-2999-3_14.
9
The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies.人乳头瘤病毒 L2 蛋白的 N 端区域包含中和、交叉中和和非中和抗体的重叠结合位点。
Virology. 2011 Jan 20;409(2):348-59. doi: 10.1016/j.virol.2010.10.017. Epub 2010 Nov 11.
10
Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7.在 RNA 噬菌体 PP7 的病毒样颗粒上免疫展示多样化的肽,包括广泛交叉型中和人乳头瘤病毒 L2 表位。
Vaccine. 2010 Jun 17;28(27):4384-93. doi: 10.1016/j.vaccine.2010.04.049. Epub 2010 Apr 29.

引用本文的文献

1
Immunodominant extracellular loops of Treponema pallidum FadL outer membrane proteins elicit antibodies with opsonic and growth-inhibitory activities.梅毒螺旋体FadL外膜蛋白的免疫显性细胞外环可引发具有调理和生长抑制活性的抗体。
PLoS Pathog. 2024 Dec 23;20(12):e1012443. doi: 10.1371/journal.ppat.1012443. eCollection 2024 Dec.
2
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity.一种具有联合预防和治疗活性的安全且增强型多类型HPV L2-E7纳米颗粒疫苗。
NPJ Vaccines. 2024 Jun 26;9(1):119. doi: 10.1038/s41541-024-00914-z.
3
Inhibitory protein-protein interactions of the SIRT1 deacetylase are choreographed by post-translational modification.

本文引用的文献

1
Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships.基于合成脂肽的候选疫苗的免疫刺激作用:构效关系
Front Immunol. 2013 Oct 9;4:318. doi: 10.3389/fimmu.2013.00318.
2
Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model.用含有 HPV-16 E6 和 E7 表位的 HPV-16 L1 嵌合病毒样颗粒免疫可在 HPV-16 肿瘤小鼠模型中产生持久的预防和治疗效果。
Arch Virol. 2014 Feb;159(2):291-305. doi: 10.1007/s00705-013-1819-z. Epub 2013 Aug 29.
3
SIRT1 去乙酰化酶的抑制蛋白-蛋白相互作用是由翻译后修饰协调的。
Protein Sci. 2024 Apr;33(4):e4938. doi: 10.1002/pro.4938.
4
Bacterial Outer Membrane Vesicles as a Platform for the Development of a Broadly Protective Human Papillomavirus Vaccine Based on the Minor Capsid Protein L2.基于次要衣壳蛋白L2的人乳头瘤病毒广谱保护性疫苗开发平台——细菌外膜囊泡
Vaccines (Basel). 2023 Oct 11;11(10):1582. doi: 10.3390/vaccines11101582.
5
Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines. positively 超荷正电的古菌硫氧还蛋白支架作为穿透细胞抗原载体增强肽疫苗的免疫原性。
Front Immunol. 2022 Aug 9;13:958123. doi: 10.3389/fimmu.2022.958123. eCollection 2022.
6
Extracellular Loops of the Treponema pallidum FadL Orthologs TP0856 and TP0858 Elicit IgG Antibodies and IgG-Specific B-Cells in the Rabbit Model of Experimental Syphilis.苍白密螺旋体 FadL 同源物 TP0856 和 TP0858 的细胞外环在实验性梅毒兔模型中引发 IgG 抗体和 IgG 特异性 B 细胞。
mBio. 2022 Aug 30;13(4):e0163922. doi: 10.1128/mbio.01639-22. Epub 2022 Jul 12.
7
Nanotechnology-Based Weapons to Combat Human Papillomavirus Infection Associated Diseases.基于纳米技术的武器对抗人乳头瘤病毒感染相关疾病
Front Chem. 2021 Nov 17;9:798727. doi: 10.3389/fchem.2021.798727. eCollection 2021.
8
RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates.RG1病毒样颗粒及其他基于L2的广谱人乳头瘤病毒候选疫苗
J Clin Med. 2021 Mar 3;10(5):1044. doi: 10.3390/jcm10051044.
9
Development of thermostable vaccine adjuvants.耐热疫苗佐剂的开发。
Expert Rev Vaccines. 2021 May;20(5):497-517. doi: 10.1080/14760584.2021.1902314. Epub 2021 Jun 26.
10
Broad Neutralization Responses Against Oncogenic Human Papillomaviruses Induced by a Minor Capsid L2 Polytope Genetically Incorporated Into Bacterial Ferritin Nanoparticles.由基因整合到细菌铁蛋白纳米颗粒中的次要衣壳L2多表位诱导产生的针对致癌性人乳头瘤病毒的广泛中和反应
Front Immunol. 2020 Dec 4;11:606569. doi: 10.3389/fimmu.2020.606569. eCollection 2020.
Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses.
RG1-VLP 疫苗接种对预防生殖器和皮肤人乳头瘤病毒感染的疗效。
J Invest Dermatol. 2013 Dec;133(12):2706-2713. doi: 10.1038/jid.2013.253. Epub 2013 May 10.
4
Development of human papillomavirus chimaeric L1/L2 candidate vaccines.人乳头瘤病毒嵌合 L1/L2 候选疫苗的研制。
Arch Virol. 2013 Oct;158(10):2079-88. doi: 10.1007/s00705-013-1713-8. Epub 2013 May 1.
5
Optimization of multimeric human papillomavirus L2 vaccines.多聚体人乳头瘤病毒 L2 疫苗的优化。
PLoS One. 2013;8(1):e55538. doi: 10.1371/journal.pone.0055538. Epub 2013 Jan 31.
6
Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.人乳头瘤病毒次要衣壳蛋白 L2 主要中和表位的天然变异。
Int J Cancer. 2013 Feb 1;132(3):E139-48. doi: 10.1002/ijc.27831. Epub 2012 Oct 3.
7
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate.开发 AAVLP(HPV16/31L2)颗粒作为广泛保护性 HPV 疫苗候选物。
PLoS One. 2012;7(6):e39741. doi: 10.1371/journal.pone.0039741. Epub 2012 Jun 27.
8
Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice.经乳杆菌展示的 HPV-16 L2 经口服给药可在 Balb/c 小鼠中诱导系统和黏膜交叉中和作用。
Vaccine. 2012 May 9;30(22):3286-94. doi: 10.1016/j.vaccine.2012.03.009. Epub 2012 Mar 15.
9
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.HPV-16/18 AS04 佐剂疫苗对 3 级或更高级别宫颈上皮内瘤变的总体疗效:随机、双盲 PATRICIA 试验的 4 年研究结束时分析。
Lancet Oncol. 2012 Jan;13(1):89-99. doi: 10.1016/S1470-2045(11)70286-8. Epub 2011 Nov 8.
10
Capsomer vaccines protect mice from vaginal challenge with human papillomavirus.衣壳疫苗可保护小鼠免受人乳头瘤病毒阴道挑战。
PLoS One. 2011;6(11):e27141. doi: 10.1371/journal.pone.0027141. Epub 2011 Nov 1.